Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience

被引：0
|
作者：
Assi, Rita
Kantarjian, Hagop M.
Keating, Michael J.
Pemmaraju, Naveen
Verstovsek, Srdan
Garcia-Manero, Guillermo
Ravandi, Farhad
Borthakur, Gautam
Dahl, Jenny
Jabbour, Elias J.
Cortes, Jorge E.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2881
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience
    Assi, Rita
    Kantarjian, Hagop
    Keating, Michael
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Dahl, Jenny
    Jabbour, Elias
    Cortes, Jorge E.
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 909 - 917
  • [2] Memory Impairment in Chronic phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Treated with Dasatinib Tyrosine Kinase Inhibitor (TKI) Therapy
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Tanaka, Maria F.
    O'Brien, Susan
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Ravandi, Farhad
    Verstovsek, Srdan
    Burton, Elizabeth
    Walker, Brenda
    Cortes, Jorge E.
    BLOOD, 2011, 118 (21) : 1610 - 1611
  • [3] Supporting Adherence to Tyrosine Kinase Inhibitor (TKI) Therapy Among Patients with Chronic Myeloid Leukemia (CML)
    Nodzon, Lisa
    Tinsley-Vance, Sara
    BLOOD, 2017, 130
  • [4] An Ethnographic Investigation Tracking the Experience of Chronic Myeloid Leukemia (CML) Patients on Tyrosine Kinase Inhibitor (TKI) Therapies
    Guilhot, Francois
    Coombs, John
    Szczudlo, Tomasz
    Zernovak, Oleg
    Macdonald, Nancy J.
    Shapiro, Ari
    BLOOD, 2010, 116 (21) : 176 - 177
  • [5] Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy
    Barber, Mary C.
    Mauro, Michael J.
    Moslehi, Javid
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 110 - 114
  • [6] Estimated Glomerular Filtration Rate Changes In Patients (Pts) With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors (TKI)
    Yilmaz, Musa
    Kantarjian, Hagop M.
    Quintas-Cardama, Alfonso
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Borthakur, Gautam
    Ravandi, Farhad
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [7] Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)
    Haznedaroglu, Ibrahim C.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
  • [8] Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML).
    Chen, Yaozhu J.
    Huang, Hui
    Divino, Victoria
    Pokras, Shibani
    Hallinan, Shawn
    Munakata, Julie
    Taylor, Catherine
    McGarry, Lisa
    Ng, Daniel
    Nieset, Christopher
    Knopf, Kevin B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Outcome of Patients (pts) with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKI) Who Have a History of Prior Malignancies
    Koller, Paul B.
    Kantarjian, Hagop M.
    Koller, Charles
    Jabbour, Elias
    O'Brien, Susan
    Verstovsek, Srdan
    Borthakur, Gautam
    Estrov, Zeev
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    BLOOD, 2011, 118 (21) : 1618 - 1618
  • [10] Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: a single-center experience
    Frikha, R.
    Elloumi, M.
    Kamoun, H.
    LEUKEMIA RESEARCH, 2019, 85 : S66 - S66
12345